Skip Navigation

Advancing Heart Health Research

Sanger Heart & Vascular Institute (SHVI) supports a cardiology research program that facilitates clinical and outcomes research with more than 40 experienced cardiovascular faculty members, an integrated care model and a high volume of patients seeking the expertise of the SHVI team.

Our research team, made up of nurses, data coordinators and support staff, works with physicians and providers to access the latest cardiovascular devices and therapies, which are only available through clinical trials. Our team also helps manage studies started by SHVI providers, allowing new information to be published and presented at national and international conferences.

Working across more than 20 sites, our research team manages more than 50 studies simultaneously throughout Atrium Health. Therapies and techniques range from minimally invasive surgery to heart transplants and across multiple specialties, including:

  • Heart failure
  • Electrophysiology
  • Vascular heart disease
  • Pediatrics
  • Interventional cardiology
  • Structural heart disease
  • Imaging
  • Cardiovascular and thoracic surgery

Participating in landmark studies over the past 50 years, our cardiology research program continues to expand its role as a regional and global leader furthering the development of breakthrough technologies.

Top Outcomes. Breakthrough Research. Better Care.

Our cardiology research faculty conduct value-based research to decrease costs and improve efficiencies and access to care and quality. Our experts work on sponsor-developed outcomes research, providing access to national and international clinical trials, as well as studies initiated within SHVI. This allows our patients to manage their cardiovascular disease using the most up-to-date medications and cutting-edge devices.

Support Cardiology Research

To conduct research at the highest level, funding is critical. If you’d like to help us as we work to improve heart health, please consider making a donation of any size.